Peter S Kim - Net Worth and Insider Trading
Peter S Kim Net Worth
The estimated net worth of Peter S Kim is at least $19 Million dollars as of 2024-12-27. Peter S Kim is the Exe V-P & Pres, MRL of Merck & Co Inc and owns about 172,039 shares of Merck & Co Inc (MRK) stock worth over $17 Million. Peter S Kim is also the Director of Entrada Therapeutics Inc and owns about 92,412 shares of Entrada Therapeutics Inc (TRDA) stock worth over $2 Million. Details can be seen in Peter S Kim's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter S Kim has not made any transactions after 2024-05-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter S Kim
Peter S Kim Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter S Kim owns 3 companies in total, including Merck & Co Inc (MRK) , Entrada Therapeutics Inc (TRDA) , and Merck & Co Inc (MRKPRB.PFD) .
Click here to see the complete history of Peter S Kim’s form 4 insider trades.
Insider Ownership Summary of Peter S Kim
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRK | Merck & Co Inc | 2012-11-05 | Exec. V-P and Pres. & MRL |
| TRDA | Entrada Therapeutics Inc | 2024-05-14 | director |
| MRKPRB.PFD | Merck & Co Inc | 2009-11-03 | Exec. V-P and Pres. & MRL |
Peter S Kim Latest Holdings Summary
Peter S Kim currently owns a total of 2 stocks. Among these stocks, Peter S Kim owns 172,039 shares of Merck & Co Inc (MRK) as of November 5, 2012, with a value of $17 Million and a weighting of 91.29%. Peter S Kim also owns 92,412 shares of Entrada Therapeutics Inc (TRDA) as of May 14, 2024, with a value of $2 Million and a weighting of 8.71%.
Latest Holdings of Peter S Kim
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRK | Merck & Co Inc | 2012-11-05 | 172,039 | 99.87 | 17,181,535 |
| TRDA | Entrada Therapeutics Inc | 2024-05-14 | 92,412 | 17.74 | 1,639,389 |
Holding Weightings of Peter S Kim
Peter S Kim Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter S Kim has made a total of 0 transactions in Merck & Co Inc (MRK) over the past 5 years. The most-recent trade in Merck & Co Inc is the sale of 420,000 shares on November 5, 2012, which brought Peter S Kim around $19 Million.
According to the SEC Form 4 filings, Peter S Kim has made a total of 6 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Entrada Therapeutics Inc is the acquisition of 25,000 shares on May 14, 2024, which cost Peter S Kim around $364,750.
Insider Trading History of Peter S Kim
- 1
Peter S Kim Trading Performance
GuruFocus tracks the stock performance after each of Peter S Kim's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter S Kim is 5.75%. GuruFocus also compares Peter S Kim's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter S Kim within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter S Kim's insider trading performs compared to the benchmark.
Performance of Peter S Kim
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.11 |  | | | | |
| Relative Return to S&P 500(%) | -0.38 | | | | | |
Peter S Kim Ownership Network
Peter S Kim Owned Company Details
What does Merck & Co Inc do?
Who are the key executives at Merck & Co Inc?
Peter S Kim is the Exec. V-P and Pres. & MRL of Merck & Co Inc. Other key executives at Merck & Co Inc include EVP & CFO Caroline Litchfield , Evp & Global Svcs & CFO Robert M Davis , and President & Human Health Int?l Joseph Romanelli .
Merck & Co Inc (MRK) Insider Trades Summary
Over the past 18 months, Peter S Kim made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 21,040 shares made by Johannes Jacobus Oosthuizen , a net sale of 8,750 shares made by Steven Mizell , and a net sale of 1,089 shares made by Joseph Romanelli .
In summary, during the past 3 months, insiders sold 0 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 364,167 shares of Merck & Co Inc (MRK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 364,167 shares.
Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merck & Co Inc Insider Transactions
Peter S Kim Mailing Address
Above is the net worth, insider trading, and ownership report for Peter S Kim. You might contact Peter S Kim via mailing address: One Merck Drive, P.o. Box 100, Whitehouse Station X1 08889.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
